Diagnosis and treatment of glucocorticoid-induced osteoporosis
Cleveland Clinic Journal of Medicine. 1999 April;66(4):221-222, 224-230
April 1, 1999|Cleveland Clinic Journal of Medicine
Author and Disclosure Information
ABSTRACT
Glucocorticoids are a mainstay in the treatment of many diseases, including pulmonary and rheumatologic disorders. Unfortunately, as many as 90% of long-term glucocorticoid recipients lose a significant amount of bone and incur an increased risk of fractures. This paper reviews the pathophysiology, diagnosis, and treatment of glucocorticoid-induced osteoporosis.
